Takeda describes heterocyclic compounds that inhibit T-cell proliferation and IL-2 production July 3, 2001
Licensing opportunity from NIH: chimeric protein with potential as antiinfective therapeutic June 22, 2001
Mutant HLA class I molecules as novel approach to xenotransplantation and bone marrow transplant June 15, 2001
CIPF obtains rights to antigen delivery technology for anticancer, antiinfectious applications June 15, 2001
RSS